The company was established in Europe in The Netherlands. The main department of described VC is located in the Laren.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Breedinvest, startups are often financed by Gilde Healthcare, Van Herk Ventures, Global Life Science Ventures. The meaningful sponsors for the fund in investment in the same round are Van Herk Ventures, Korys, ING Corporate Investments. In the next rounds fund is usually obtained by Norgine Ventures, EASME - EU Executive Agency for SMEs, Athyrium Capital Management, LP.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Agendia Among the most popular fund investment industries, there are Genetics, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands.
The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2012.
Related Funds
Funds with similar focus
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.